Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €1 | €1 | €1 | €1 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €1 | €1 | €1 | €1 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| EBITDA | €0 | €0 | €0 | -€0 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |
| Net Income | €0 | €0 | €0 | -€0 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | €0 | €0 | €0 |